Linked Data API

Show Search Form

Search Results

1698328
registered interest false more like this
date less than 2024-03-25more like thismore than 2024-03-25
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Rare Diseases: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many appraisals for medicines to treat very rare diseases were started through the National Institute for Health and Care Excellence highly specialised technology programme in each financial year since 2018-19. more like this
tabling member constituency Bootle remove filter
tabling member printed
Peter Dowd more like this
uin 20317 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-15more like thismore than 2024-04-15
answer text <p>The following table from the National Institute for Health and Care Excellence (NICE) shows the number of highly specialised technology evaluations that started in each year since 2018/2019:</p><table><tbody><tr><td><p>Year</p></td><td><p>Invitations To Participate</p></td></tr><tr><td><p>2018/19</p></td><td><p>4</p></td></tr><tr><td><p>2019/20</p></td><td><p>2</p></td></tr><tr><td><p>2020/21</p></td><td><p>3</p></td></tr><tr><td><p>2021/22</p></td><td><p>7</p></td></tr><tr><td><p>2022/23</p></td><td><p>8</p></td></tr><tr><td><p>2023/24</p></td><td><p>4</p></td></tr><tr><td><p>Total</p></td><td><p>28</p></td></tr></tbody></table><p>Note: The term started has been defined as when the NICE sent the invitation to participate.</p> more like this
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
question first answered
less than 2024-04-15T08:58:55.847Zmore like thismore than 2024-04-15T08:58:55.847Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4397
label Biography information for Peter Dowd more like this
1694525
registered interest false more like this
date less than 2024-03-07more like thismore than 2024-03-07
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cancer: Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether she has held discussions with NHS England on the need for a dedicated and specific cancer plan. more like this
tabling member constituency Bootle remove filter
tabling member printed
Peter Dowd more like this
uin 17562 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-14more like thismore than 2024-03-14
answer text <p>The Department works closely with NHS England on a wide range of issues relating to cancer, and to deliver the key priorities on cancer as set out in the NHS Long Term Plan. Current priorities include work on improving cancer survival rates through earlier diagnosis, and reducing cancer treatment waiting times across England, including the time between an urgent general practice referral and the commencement of treatment. The Government is working jointly with NHS England on implementing the delivery plan for tackling the COVID-19 backlogs in elective care, and plans to spend more than £8 billion from 2022/23 to 2024/25 to help drive up and protect elective activity, including cancer diagnosis and treatment activity.</p><p>On 14 August 2023, the Government published a strategic framework for the Major Conditions Strategy to consider the six conditions, including cancer, that contribute most to morbidity and mortality across the population in England. This is because we recognise that most cancer patients will have at least one other condition, so we are developing a Major Conditions Strategy that will include cancer. The Major Conditions Strategy will apply a geographical lens to each condition, to address regional disparities in health outcomes, supporting the levelling up mission to narrow the gap in healthy life expectancy by 2030.</p>
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
question first answered
less than 2024-03-14T17:55:22.117Zmore like thismore than 2024-03-14T17:55:22.117Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4397
label Biography information for Peter Dowd more like this